Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Abstract

Among patients hospitalized in metropolitan New York with COVID-19, treatment with hydroxychloroquine, azithromycin, or both, compared with neither treatment, was not significantly associated with differences in in-hospital mortality. However, the interpretation of these findings may be limited by the observational design.

Keywords

HydroxychloroquineMedicineAzithromycinRetrospective cohort studyInternal medicineMedical recordPediatricsAdverse effectCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission

Jennifer Lighter , Michael Phillips , Sarah Hochman +4 more

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital AdmissionTo the Editor-Risk factors for infectious disease severity are determined by the pathog...

2020 Clinical Infectious Diseases 1279 citations

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Matthew J. Cummings , Matthew R. Baldwin , Darryl Abrams +12 more

Over 40 000 patients with COVID-19 have been hospitalised in New York City (NY, USA) as of April 28, 2020. Data on the epidemiology, clinical course, and outcomes of crit...

2020 The Lancet 2258 citations

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi , Mu Qin , Bo Shen +10 more

Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality.

2020 JAMA Cardiology 4474 citations

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang , Lihua Zhu , Jingjing Cai +41 more

Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major concern for clinicians treating coronavirus disease 201...

2020 Circulation Research 1170 citations

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Christopher M. Petrilli , Simon Jones , Jie Yang +7 more

Abstract Objective To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteris...

2020 BMJ 2899 citations

Publication Info

Year: 2020
Type: article
Volume: 323
Issue: 24
Pages: 2493-2493
Citations: 1220
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1220

OpenAlex

Cite This

APA Style

                            
                                
                                    Eli S. Rosenberg, 
                                
                                    Elizabeth Dufort, 
                                
                                    Tomoko Udo
                                
                                et al.
                            
                            (2020). 
                            Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. 
                            JAMA
                            , 323
                            (24)
                            , 2493-2493.
                            https://doi.org/10.1001/jama.2020.8630
                        

Identifiers

DOI: 10.1001/jama.2020.8630